1、订购使用抗体产品的客户,在使用产品过程中遇到问题,提出技术支持及其他请求时,我公司接到请求后的24个小时之内做出处理。
2、我公司的所有产品都经过严格的质检后上架销售,如经复核确实存在问题,本公司无条件退款或更换货。
3、所有书面反馈我们收到后48小时内给出答复。
Product Details
- Verified Reactivity
- Mouse
- Antibody Type
- Monoclonal
- Host Species
- Rat
- Immunogen
- Mouse B7-DC transfected cell line
- Formulation
- 0.2 ?m filtered in phosphate-buffered solution, pH 7.2, containing no preservative. Endotoxin level is <0.01 EU/?g of the protein (<0.001 ng/?g of the protein) as determined by the LAL test.
- Preparation
- The Ultra-LEAF? (Low Endotoxin, Azide-Free) antibody was purified by affinity chromatography.
- Concentration
- The antibody is bottled at the concentration indicated on the vial, typically between 2 mg/mL and 3 mg/mL. Older lots may have also been bottled at 1 mg/mL. To obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C. This Ultra-LEAF? solution contains no preservative; handle under aseptic conditions.
- Application
-
FC - Quality tested
IHC-F, IP, WB - Reported in the literature, not verified in house - Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.
- Application Notes
Additional reported applications (for the relevant formats) include: immunoprecipitation1, Western blotting1,6, blocking2,4,5 of PD-1 mediated interactions, and immunohistochemistry of acetone-fixed frozen sections3. The Ultra-LEAF? purified antibody (Endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays (Cat. Nos. 107221-107226).
- Application References
(PubMed link indicates BioLegend citation) -
- Yamazaki T, et al. 2002. J. Immunol. 169:5538. (FC, IP, WB)
- Ansari MJI, et al. 2003. J. Exp. Med. 198:63. (Block)
- Salama AD, et al. 2003. J. Exp. Med. 198:71. (IHC)
- Matsumoto K, et al. 2004. J. Immunol. 172:2530. (FC, Block)
- Yamazaki T, et al. 2005. J. Immunol. 175:1586. (Block)
- Meng Q, et al. 2006. Invest Opthalmol Vis Sci. 47:444. (WB) PubMed
- del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
- Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
- RRID
- AB_2813956 (BioLegend Cat. No. 107221) AB_2813957 (BioLegend Cat. No. 107222) AB_2813958 (BioLegend Cat. No. 107223) AB_2813959 (BioLegend Cat. No. 107224) AB_2813960 (BioLegend Cat. No. 107225) AB_2813961 (BioLegend Cat. No. 107226)
Antigen Details
- Structure
- B7 Immunoglobulin superfamily, 42 kD
- Distribution
-
Dendritic cells, liver, few transformed cell lines, subset of macrophages; not expressed on lymphoid tissues
- Function
- Binds to PD-1 and alternative receptor; ligation on DC stimulates, inhibits T cell responses via PD-1 binding, stimulates T cells via alternative receptor binding and promotes tumor immunity
- Ligand/Receptor
- PD-1, uncharacterized receptor
- Cell Type
- Dendritic cells, Macrophages
- Biology Area
- Costimulatory Molecules, Immunology
- Molecular Family
- CD Molecules, Immune Checkpoint Receptors
- Antigen References
-
1. Shin T, et al. 2003. J. Exp. Med. 198:31.
2. Liu X, et al. 2003. J. Exp. Med. 197:1721.
3. Carreno BM, et al. 2002. Annu. Rev. Immunol. 20:29. - Gene ID
- 58205 View all products for this Gene ID
- UniProt
- View information about CD273 on UniProt.org